Although we do not have a follow-up in the likelihood evidence of lung cancer for these subjects and patients, it is likely that the higher levels of the circulating caspase-4 compared to healthy subjects are predictive for a high risk of lung malignancy. The gene discussed is CASP4; the disease is lung carcinoma.